Spire Healthcare Group plc (LON:SPI - Get Free Report) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 237.59 ($3.00) and traded as low as GBX 224.50 ($2.83). Spire Healthcare Group shares last traded at GBX 228.50 ($2.88), with a volume of 232,197 shares traded.
Analysts Set New Price Targets
Separately, Berenberg Bank restated a "buy" rating and set a GBX 300 ($3.79) price objective on shares of Spire Healthcare Group in a report on Tuesday, September 17th.
Get Our Latest Analysis on Spire Healthcare Group
Spire Healthcare Group Price Performance
The company has a debt-to-equity ratio of 169.51, a current ratio of 0.70 and a quick ratio of 0.74. The stock has a fifty day simple moving average of GBX 222.03 and a 200-day simple moving average of GBX 237.33. The company has a market capitalization of £922.73 million, a price-to-earnings ratio of 3,264.29, a P/E/G ratio of 1.06 and a beta of 0.96.
Insider Buying and Selling at Spire Healthcare Group
In related news, insider Justin Ash bought 21,100 shares of the business's stock in a transaction dated Tuesday, September 17th. The stock was acquired at an average price of GBX 236 ($2.98) per share, with a total value of £49,796 ($62,849.93). 34.71% of the stock is owned by corporate insiders.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
See Also
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
